Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SUNITINIB MALATE Cause Platelet count increased? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Platelet count increased have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 0.1% of all adverse event reports for SUNITINIB MALATE.

17
Reports of Platelet count increased with SUNITINIB MALATE
0.1%
of all SUNITINIB MALATE reports
6
Deaths
11
Hospitalizations

How Dangerous Is Platelet count increased From SUNITINIB MALATE?

Of the 17 reports, 6 (35.3%) resulted in death, 11 (64.7%) required hospitalization, and 1 (5.9%) were considered life-threatening.

Is Platelet count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SUNITINIB MALATE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does SUNITINIB MALATE Cause?

Death (4,385) Diarrhoea (3,044) Fatigue (2,865) Nausea (2,032) Neoplasm progression (1,920) Disease progression (1,745) Decreased appetite (1,676) Asthenia (1,651) Vomiting (1,331) Dysgeusia (1,226)

What Other Drugs Cause Platelet count increased?

RUXOLITINIB (1,667) ELTROMBOPAG OLAMINE (980) CLOZAPINE (745) PREDNISONE (433) ADALIMUMAB (404) RITUXIMAB (400) METHOTREXATE (356) INFLIXIMAB (225) OMALIZUMAB (223) MONTELUKAST (211)

Which SUNITINIB MALATE Alternatives Have Lower Platelet count increased Risk?

SUNITINIB MALATE vs SUTENT SUNITINIB MALATE vs SUTIMLIMAB-JOME SUNITINIB MALATE vs SUVOREXANT SUNITINIB MALATE vs SUZETRIGINE SUNITINIB MALATE vs SYMBICORT

Related Pages

SUNITINIB MALATE Full Profile All Platelet count increased Reports All Drugs Causing Platelet count increased SUNITINIB MALATE Demographics